טוען...
Clinical response to adalimumab: relationship to anti‐adalimumab antibodies and serum adalimumab concentrations in rheumatoid arthritis
BACKGROUND: A substantial proportion of patients with rheumatoid arthritis (RA) do not respond, or lose initial response, to adalimumab treatment. One explanation for non‐response is that patients develop anti‐adalimumab antibodies. OBJECTIVES: To evaluate the incidence of formation of antibody agai...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
BMJ Group
2007
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1955110/ https://ncbi.nlm.nih.gov/pubmed/17301106 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ard.2006.065615 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|